Hemophilia A in infantsEffective prophylaxis with emicizumab possible at an early stage

被引：0
|
作者：
Burggraf, Leoni
机构：
来源：
TRANSFUSION MEDICINE AND HEMOTHERAPY | 2023年 / 50卷 / 05期
关键词：
D O I：
10.1159/000534222
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A BOY WITH HEMOPHILIA A WITHOUT INHIBITORS IN PROPHYLAXIS WITH EMICIZUMAB IN PORTUGAL: IS HE THE FIRST OF MANY?
    Campanico, S.
    Catarino, C.
    Rodrigues, F.
    Pereira, A.
    HAEMOPHILIA, 2022, 28 : 35 - 35
  • [42] Emicizumab in Hemophilia A Reply
    Aledort, Louis M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 786 - 786
  • [43] COST-CONSEQUENCE ANALYSIS OF EMICIZUMAB PROPHYLAXIS FOR SEVERE HEMOPHILIA A PATIENTS WITHOUT INHIBITORS
    Cortesi, P. A.
    Castaman, G.
    Mantovani, L. G.
    VALUE IN HEALTH, 2020, 23 : S696 - S696
  • [44] Emicizumab Prophylaxis in Hemophilia A High Therapy Adherence thanks to subcutaneous Administration and rare Injections
    不详
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2021, 48 (02) : I - II
  • [45] Management and Outcomes of Invasive Procedures in Individuals with Hemophilia A on Emicizumab Prophylaxis: A Single Center Experience
    Rener, Karla
    Anzej Doma, Sasa
    Fink, Martina
    Podgornik, Helena
    Preloznik Zupan, Irena
    Cerchione, Claudio
    Zanon, Ezio
    HEMATOLOGY REPORTS, 2023, 15 (04) : 597 - 607
  • [46] Hemophilia A High Benefit of Emicizumab confirmed in Practice: High Bleeding Protection in Routine Prophylaxis
    Hamophilie, A.
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2020, 47 (02) : 190 - 191
  • [47] Emicizumab prophylaxis in a Korean child with severe hemophilia A and high titer inhibitor: a case report
    Ahn, Ji Hyun
    Jung, Nani
    Shim, Ye Jee
    Kim, Heung Sik
    BLOOD RESEARCH, 2021, 56 (01) : 44 - 46
  • [48] COST MINIMIZATION ANALYSIS OF EMICIZUMAB IN THE PROPHYLAXIS OF INHIBITOR-NEGATIVE PATIENTS WITH HEMOPHILIA A IN TURKEY
    Guler, B.
    Oksuz, E.
    Malhan, S.
    Yanik, L.
    Koc, E.
    VALUE IN HEALTH, 2019, 22 : S851 - S851
  • [49] Post-Marketing Clinical Experience of Emicizumab Prophylaxis for 13 Pediatric Patients With Hemophilia A
    Mizumachi, Kuniyoshi
    Ogiwara, Kenichi
    Furukawa, Shoko
    Yada, Koji
    Takeyama, Masahiro
    Nogami, Keiji
    Shima, Midori
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S72 - S72
  • [50] Reliable Routine Prophylaxis, Relief for Patients Clinical Experience with Emicizumab in Hemophilia A without Inhibitors
    Neubacher, Daniel
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2019, 46 (04) : 294 - 297
12345